Universities innovate, Big Pharma develops: Public and philanthropic funding crucial to treat cancer



Universities innovate, Big Pharma develops: Public and philanthropic funding crucial to treat cancer
As FRANCE 24 marks World Cancer Day, Franรงois Picard welcomes Lars Henning Milman Engelholm, Associate Professor and Group Leader at the Finsen Laboratory, Rigshospitalet / Biotech Research & Innovation Centre (BRIC), University of Copenhagen. From his lab in Copenhagen, Professor Engelholm describes a seismic shift underway in pancreatic cancer research, the result of a decade-long commitment to the steady evolution of translational science.
]

Leave a Reply

Your email address will not be published. Required fields are marked *